go-v.orgdoi

Novel treatment strategies for patients with nonalcoholic fatty liver disease

Brian P Lam, Zobair M. Younossi · Clinical Investigation · 2011

  • DOI 10.4155/cli.10.24
  • Publisher OMICS Publishing Group
  • Type article
  • Issued 2011

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Clinical Investigation · OMICS Publishing Group · article · 2011

Abstract

Nonalcoholic fatty liver disease (NAFLD), the hepatic manifestation of the metabolic syndrome, affects up to 30% of the population. As with the obesity and diabetes epidemic, NAFLD is a significant public health concern. Compared to other chronic liver diseases, management options for NAFLD are limited. While current treatment focuses on weight loss and management of cardiometabolic risk factors, significant weight loss is difficult to achieve and maintain. Two decades of research have produced numerous potential treatments, all hindered by various limitations.

Vitamin E may be effective for some patients with nonalcoholic steatohepatitis, but more treatment options are needed, and several promising agents are under investigation. We review treatment strategies previously studied and briefly survey potential treatments on the horizon.

Open the resolved locator · 10.4155/cli.10.24

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-20 12:19 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://doi.org/10.4155/cli.10.24
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.